Clinical trials
Terminated Phase 2 Cognition Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Birte Glenthoj | 1 |
| Charite University, Berlin, Germany | 1 |
| HealthPartners Institute | 1 |
| National Institute of Mental Health (NIMH) | 1 |
| Technical University of Munich | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognition Disorders | 5 |
| Schizophrenia | 2 |
| Alzheimer Disease | 1 |
| Cognitive Dysfunction | 1 |
| Memory Disorders | 1 |
| Neurofibromatosis 1 | 1 |
| Noonan Syndrome | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.